Finance

Beta
Lists
Z1TS34:BVMF
Zoetis Inc Bdr
23,80 BRL
0,00%
(0,00) 1D
2-июн., 16:56:00 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for Z1TS34...
Open
24,48 BRL
High
24,48 BRL
Low
23,80 BRL
Mkt. cap
32,02 млд
Avg. vol.
4,11 миң
Volume
6,72 миң
52-wk high
59,98 BRL
52-wk low
23,00 BRL
Shares outstanding
419,23 млн
No. of employees
14 миң
Open
24,48 BRL
High
24,48 BRL
Low
23,80 BRL
Mkt. cap
32,02 млд
Avg. vol.
4,11 миң
Volume
6,72 миң
52-wk high
59,98 BRL
52-wk low
23,00 BRL
Shares outstanding
419,23 млн
No. of employees
14 миң
News stories
From sources across the web
Profile
Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index. Wikipedia
About Zoetis Inc Bdr
CEOKristin C. Peck
Employees14,5 миң
Founded1952
HeadquartersParsippany-Troy Hills, Нью Джерси, Америка Кошмо Штаттары
SectorPharmaceutical industry
Websitezoetis.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
Revenue
2,46 млд
2,40 млд
2,39 млд
2,26 млд
Cost of goods sold
647,00 млн
682,00 млн
711,00 млн
640,00 млн
Cost of revenue
647,00 млн
682,00 млн
711,00 млн
640,00 млн
Research and development expenses
172,00 млн
170,00 млн
199,00 млн
180,00 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
608,00 млн
572,00 млн
618,00 млн
584,00 млн
Operating expense
813,00 млн
774,00 млн
848,00 млн
795,00 млн
Total operating expenses
1,46 млд
1,46 млд
1,56 млд
1,44 млд
Operating income
1,00 млд
944,00 млн
828,00 млн
827,00 млн
Other non operating income
-1,00 млн
-
-6,00 млн
-1,00 млн
EBT including unusual items
902,00 млн
887,00 млн
761,00 млн
758,00 млн
EBT excluding unusual items
951,00 млн
899,00 млн
780,00 млн
779,00 млн
Income tax expense
184,00 млн
166,00 млн
158,00 млн
157,00 млн
Effective tax rate
20,40%
18,71%
20,76%
20,71%
Other operating expenses
-
-
-
-
Net income
718,00 млн
721,00 млн
603,00 млн
601,00 млн
Net profit margin
29,19%
30,04%
25,26%
26,57%
Earnings per share
1,76
1,70
1,48
1,53
Interest and investment income
19,00 млн
26,00 млн
25,00 млн
21,00 млн
Interest expense
-53,00 млн
-58,00 млн
-57,00 млн
-62,00 млн
Net interest expenses
-34,00 млн
-32,00 млн
-32,00 млн
-41,00 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
1,12 млд
1,07 млд
903,00 млн
946,00 млн
Gain or loss from assets sale
3,00 млн
-
-
-6,00 млн
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more